A randomized phase III study of taxotere (T) versus doxorubicin (D) in patients (pts) with metastatic breast cancer (MBC) who have failed an alkylating containing regimen; Preliminary results

• CHAN S.

収録刊行物

• Proc Am Soc Clin Oncol

  Proc Am Soc Clin Oncol 16 154a-, 1997

詳細情報

• CRID: 1572543024531079040
• NII論文ID: 10008094935
• データソース種別:
  • CiNii Articles